Help for the Heart
(L-R) Dr Tan, Dr Burke, and Dr Colin from Nuevocor.
Nuevocor is developing new solutions in gene therapies to overcome heart failure. Founding Chief Executive Dr Tan Yann Chong elaborates on its work.
The Singapore Therapeutics Development Review (STDR) is a national level funding scheme in RIE2025 that is implemented by A*STAR in partnership with its strategic partners, National Health Innovation Centre (NHIC), Singapore-MIT Alliance for Research and Technology (SMART), and the Experimental Drug Development Centre (EDDC).
It aims to support the HHP domain’s goals of creating economic value by boosting the quality and quantity of the biotechnology pipeline in Singapore.
Click here for the full article.